Prediabetes syndrome
Therapeutic area
Metabolic Disease
Rare disease
No
- Definition
- A condition in which blood glucose levels are high, but not high enough to be classified as type 2 diabetes.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Prediabetes syndrome
- Therapeutic area
- Metabolic Disease
- prediabetes syndrome
- borderline diabetes
- Impaired Glucose Tolerance (Prediabetes)
- Metformin, Prediabetes
- prediabetes
- Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
- All therapeutic areas
- Metabolic Disease
Sources for recorded values
- Severity
- Mild
- MONDO ID
- MONDO:0006920
- Parent condition
- MONDO:0002908
Related records
Broader conditions (5)
- Disease
- Disease by developmental or physiological process
- Glucose metabolism disease
- Human disease
- Metabolic disease
Trials (1,063)
- (DDS) in India: a Screening Tool to Identify Prediabetes and Undiagnosed Type 2 Diabetes in Dental Settings
- (Pakistan Diabetes Prevention Program PDPP)
- 15-minute Individual Consultation to Improve Blood Glucose Control in Pre-diabetes
- 18F-FDOPA PET/CT Imaging in Patients Undergoing Metabolic Surgery
- 2-A-Day Study: Twice a Day Meals Study.
- A Clinical Study to Evaluate the Effects of Akkermansia Muciniphila and Berberine on Prediabetes Among Obese Subjects.
- A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes
- A Comparison Between the Effects of Conventional Diets vs Intermittent Fasting Diabetic and Pre-diabetic Patients
- A Digital Therapy for Diabetes Prevention Among Overweight Adults in Terengganu, Malaysia
- A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes
- A Lifestyle Change Program to Prevent Type 2 Diabetes
- A Low-Carbohydrate Diabetes Prevention Program
- A Mediterranean Intervention on Prediabetic Children
- A Mindfulness-based Intervention for Adolescents With Prediabetes or Type 2 Diabetes
- A Mobile Phone-based Program for Adults With Prediabetes
- A Pharmacist-Coordinated Implementation of the Diabetes Prevention Program
- A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome (3ELM Study)
- A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Gastrointestinal Microbiome
- A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes
- A Prescription for Health Equity: A Healthcare Provider-based Produce Prescription Program for People With Prediabetes and Type 2 Diabetes
Drugs in development (53)
- (+)-epicatechin Phase 1
- Acipimox Phase 2
- Alcohol Phase 3
- Anakinra Phase 2
- Arginine Phase 3
- Atropine Phase 1
- Bazedoxifene Phase 2
- Berberine Phase 2
- Berberine sulfate Phase 2
- Betaine Phase 2
- Betaine hydrochloride Phase 2
- Bifidobacterium SPP. Phase 2
- Calcitriol Phase 1
- Cenicriviroc Phase 2
- Cholecalciferol Phase 2
- Cibinetide Phase 2
- Clindamycin Phase 2
- Colesevelam Phase 3
- Colesevelam hydrochloride Phase 3
- Dapagliflozin Phase 3
Other linked drugs (9)
- Allopurinol
- Atorvastatin
- Canagliflozin
- Ergocalciferol
- Niacin
- Repaglinide
- Sodium phenylbutyrate
- Tacrolimus
- Varenicline